Back to search

Article

ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study

2020-05-01

Abstract excerpt

<h4>Aims</h4> The question of interactions between the renin angiotensin aldosterone system drugs and the incidence and prognosis of COVID-19 infection has been raised by the medical community. We hypothesised that if patients treated with ACE inhibitors (ACEI) or AT1 receptor blockers (ARB) were more prone to SARS-CoV2 infection and had a worse prognosis than untreated patients, the prevalence of consumption of t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad2a42bb-68bb-5738-bf84-62bb56a77793
DOI
10.1101/2020.04.28.20078071
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID studyDOI 10.1101/2020.04.28.20078071
Select a neighboring publication to make it the new centre.